Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
583 studies found for:    "Lupus"
Show Display Options
Rank Status Study
21 Completed A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Lupuzor;   Drug: Placebo
22 Recruiting Nelfinavir in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Nelfinavir
23 Suspended Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Condition: Systemic Lupus Erythematosus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
24 Active, not recruiting Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
Condition: Systemic Lupus Erythematosus
Interventions: Drug: MT-1303 Low dose;   Drug: MT-1303 High dose
25 Unknown  The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study
Condition: Systemic Lupus Erythematosus
Intervention: Other: non-interventional
26 Recruiting High Quality Evidence of Chinese Lupus Nephritis (HELP)
Condition: Lupus Nephritis
Intervention: Other: No Intervention
27 Unknown  To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
Condition: Lupus
Intervention: Drug: Prasterone (GL701)
28 Completed Balancing Lupus Experiences With Stress Strategies
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Arthritis Self Management Program
29 Active, not recruiting A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: CC-220;   Drug: Placebo
30 Completed Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Condition: Discoid Lupus Erythematosus
Intervention: Drug: CC-10004
31 Completed
Has Results
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: IVIg
32 Completed Omega 3 Fatty Acids and Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Dietary Supplement: Hiomega-3 supplement of Naturalis® company -
33 Active, not recruiting Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Hematopoietic stem cell transplantation
34 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
35 Completed Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Cholecalciferol
36 Completed Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: ACT-334441;   Drug: Placebo
37 Terminated Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition: Discoid Lupus Erthematosus of the Scalp.
Intervention: Drug: Raptiva (efalizumab)
38 Recruiting Aurinia Renal Response in Active Lupus With Orelvo (Voclosporin)
Condition: Lupus Nephritis
Interventions: Drug: Voclosporin;   Drug: Placebo Oral Capsule
39 Terminated Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
Condition: Lupus Nephritis
Intervention: Biological: Rituximab
40 Recruiting Walk With Ease Program For Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Other: "Walk With Ease"

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.